Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10030034
Heterocycle amines and uses thereof
granted -
US 10030061
Hepcidin analogues and uses thereof
granted -
US 10030089
Sugar free, statistical copolymers made from at least three monomers
granted -
US 10029017
Pretargeted activatable cell penetrating peptide with intracellularly releasable prodrug
granted -
US 10029987
Therapeutic compounds and compositions
granted -
US 10028983
Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life
granted -
US 10028999
PAR-1 based therapeutic conjugates and uses thereof
granted -
US 10028980
Compositions and methods for transplantation of colon microbiota
granted -
US 10028968
Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications
granted -
US 10028960
Pyrimidine compounds as JAK kinase inhibitors
granted -
US 10028974
MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes
granted -
US 10028961
Therapeutically active compounds and their methods of use
granted -
US 10028946
Treating pain in patients with hepatic impairment
granted -
US 10028932
Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
granted -
US 10028939
Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of disease
granted -
US 10028936
Compositions and methods employing Wolbachia FtsZ as a target for Albendazole sulfone
granted -
US 10028911
Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent
granted -
US 10030011
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
granted -
US 10029080
Method for delivering exenatide into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 10028992
Methods of treating muscular dystrophy
granted -
US 10028949
Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
granted -
US 10029988
HDAC inhibitors
granted -
US 10030244
Serpina1 iRNA compositions and methods of use thereof
granted -
US 10028944
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.